Covaxin has completed only two of three required trial phases (File) New Delhi: Phase 3 clinical trial results for Bharat Biotech’s coronavirus vaccine – Covaxin – were released Wednesday afternoon, … Read Article
Image Source : NARENDRA MODI/TWITTER ‘Assam, Kerala, Puducherry…’: Opposition points at ‘poll link’ as PM Modi gets vaccine jab Prime Minister Narendra Modi’s decision to take his first dose of … Read Article
New Delhi: Brazil’s Health Ministry has signed an exclusive contract with India’s Bharat Biotech, under which the pharma giant will ship 20 million doses to the country between March and … Read Article
Image Source : PTI Prime Minister Narendra Modi addresses public meeting in Coimbatore. World Health Organisation (WHO) director-general Tedros Adhanom Ghebreyesus has thanked PM Modi for supporting vaccine equity, amid the pandemic. … Read Article
New Delhi: India is on a roll as it plans to start phase two of coronavirus vaccination programme after very successful first phase that began on January 16 with two … Read Article
Image Source : PTI Consignment of Covishield vaccine sent by India arrives in Dhaka. (File photo) India is being lavishly praised in the international media for its vaccine diplomacy and … Read Article
Covaxin is being used in clinical trial mode, meaning its recipients are being monitored. New Delhi: Union minister Dr Harsh Vardhan today wrote to Chhattisgarh health minister TS Singh Deo, … Read Article
Image Source : PTI Canadian PM Justin Trudeau calls PM Modi, talks about Canada’s requirement of COVID-19 vaccines from India. Canadian Prime Minister Justin Trudeau on Wednesday called on Prime … Read Article
New Delhi: India commenced world’s biggest vaccination drive in the world on January 16 with two approved vaccines — Covishield and Covaxin with rave outcomes. According to the data released … Read Article
Image Source : AP Vials of COVID-19 vaccine are seen before they are packed in India. In what could be said as a proud moment for India, Brazilian President Jair … Read Article
